말초동맥질환 치료 시장 : 세계 산업 분석, 규모, 점유율, 성장, 동향, 예측(2025-2035년)
Peripheral Arterial Disease Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025-2035
상품코드:1721213
리서치사:Transparency Market Research
발행일:2025년 03월
페이지 정보:영문 245 Pages
라이선스 & 가격 (부가세 별도)
한글목차
말초동맥질환 치료 시장 : 조사 범위
TMR의 보고서 "세계 말초동맥질환 치료 시장"은 2025-2035년 예측 기간 동안 시장 지표에 대한 귀중한 인사이트를 얻기 위해 과거뿐만 아니라 현재의 성장 동향과 기회를 조사하고 있습니다. 이 보고서는 2019년부터 2035년까지의 세계 말초동맥질환 치료 시장의 수익과 예측을 제공하고자 2025년을 기준 연도로, 2035년을 예측 연도로 설정했습니다. 또한, 2025-2035년 세계 말초동맥질환 치료 시장의 CAGR%도 제공합니다.
이 보고서는 광범위한 조사를 통해 작성되었습니다. 1차 조사에서 애널리스트는 주요 오피니언 리더, 업계 리더, 오피니언 메이커를 대상으로 인터뷰를 진행했습니다. 2차 조사에서는 주요 기업의 제품 자료, 연례 보고서, 보도 자료, 관련 자료 등을 참고하여 말초동맥질환 치료 시장을 이해하고자 했습니다.
시장 스냅샷
2024년 시장 규모
29억 달러
2035년 시장 규모
64억 달러
CAGR
7.5%
이 보고서는 세계 말초동맥질환 치료 시장의 경쟁 환경을 조사하고 있습니다. 세계 말초동맥질환 치료 시장에서 활동하는 주요 업체를 식별하고, 각 업체는 다양한 속성별로 프로파일을 작성했습니다. 기업 개요, 재무 상태, 최근 동향, SWOT 등 세계 말초동맥질환 치료 시장의 기업 속성이 본 보고서에서 소개됩니다.
목차
제1장 서문
제2장 가정과 조사 방법
제3장 주요 요약 : 세계 시장
제4장 시장 개요
소개
개요
시장 역학
세계의 말초동맥질환 치료 시장 분석과 예측(2020-2035년)
제5장 주요 인사이트
주요 지역/국가의 규제 상황
시장 동향
Porter's Five Forces 분석
PESTEL 분석
최종사용자에 대한 주요 구입 지표
브랜드와 가격 분석
치료 알고리즘
주요 업계 이벤트
제6장 세계의 시장 분석과 예측 : 약물 유형별
소개와 정의
주요 조사 결과/진전
시장 금액 예측 : 약물 유형별(2020-2035년)
항혈소판제
콜레스테롤 저하제(스타틴)
강압제
혈압약
혈관확장제
기타
시장 매력 : 약물 유형별
제7장 세계의 시장 분석과 예측 : 투여 경로별
소개와 정의
주요 조사 결과/진전
시장 금액 예측 : 투여 경로별(2020-2035년)
경구
비경구
시장 매력 : 투여 경로별
제8장 세계의 시장 분석과 예측 : 유통 채널별
소개와 정의
주요 조사 결과/진전
시장 금액 예측 : 유통 채널별(2020-2035년)
원내 약국
소매 약국
온라인 약국
시장 매력 : 유통 채널별
제9장 세계의 시장 분석과 예측 : 지역별
주요 조사 결과
시장 금액 예측 : 지역별
북미
유럽
아시아태평양
라틴아메리카
중동 및 아프리카
시장 매력 : 지역별
제10장 북미의 시장 분석과 예측
미국
캐나다
제11장 유럽의 시장 분석과 예측
독일
영국
프랑스
이탈리아
스페인
기타 유럽
제12장 아시아태평양의 시장 분석과 예측
중국
일본
인도
호주와 뉴질랜드
기타 아시아태평양
제13장 라틴아메리카의 시장 분석과 예측
브라질
멕시코
기타 라틴아메리카
제14장 중동 및 아프리카의 시장 분석과 예측
GCC 국가
남아프리카공화국
기타 중동 및 아프리카
제15장 경쟁 구도
시장 기업 : 경쟁 매트릭스(기업 계층별·규모별)
시장 점유율 분석 : 기업별(2024년)
기업 개요
Bayer AG
Pfizer Inc.
Eli Lilly and Company
Cipla
Lupin
Viatris Inc
Johnson & Johnson Services, Inc.
Sanofi
Novartis AG
Amgen Inc.
Aurobindo Pharma Limited
기타
ksm
영문 목차
영문목차
Peripheral Arterial Disease Treatment Market - Scope of Report
TMR's report on the global peripheral arterial disease treatment market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2025 to 2035. The report provides revenue of the global peripheral arterial disease treatment market for the period 2019-2035, considering 2025 as the base year and 2035 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global peripheral arterial disease treatment market from 2025 to 2035.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the peripheral arterial disease treatment market.
Market Snapshot
Market Value in 2024
US$ 2.9 Bn
Market Value in 2035
US$ 6.4 Bn
CAGR
7.5%
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global peripheral arterial disease treatment market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global peripheral arterial disease treatment market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global peripheral arterial disease treatment market.
The report delves into the competitive landscape of the global peripheral arterial disease treatment market. Key players operating in the global peripheral arterial disease treatment market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global peripheral arterial disease treatment market profiled in this report.
Key Questions Answered in Global peripheral arterial disease treatment market Report:
What is the sales/revenue generated by peripheral arterial disease treatment across all regions during the forecast period?
What are the opportunities in the global peripheral arterial disease treatment market?
What are the major drivers, restraints, opportunities, and threats in the market?
Which regional market is set to expand at the fastest CAGR during the forecast period?
Which segment is expected to generate the highest revenue globally in 2035?
Which segment is projected to expand at the highest CAGR during the forecast period?
What are the market positions of different companies operating in the global market?
Peripheral Arterial Disease Treatment Market - Research Objectives and Research Approach
The comprehensive report on the global peripheral arterial disease treatment market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.
For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.
The report analyzes the global peripheral arterial disease treatment market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2035 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global peripheral arterial disease treatment market.
Table of Contents
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary : Global Peripheral Arterial Disease Treatment Market
4. Market Overview
4.1. Introduction
4.1.1. Segment Definition
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Peripheral Arterial Disease Treatment Market Analysis and Forecasts, 2020-2035
4.4.1. Market Revenue Projections (US$ Bn)
5. Key Insights
5.1. Regulatory Landscape across Key Regions / Countries
5.2. Market Trends
5.3. PORTER's Five Forces Analysis
5.4. PESTEL Analysis
5.5. Key Purchase Metrics for End-users
5.6. Brand and Pricing Analysis
5.7. Treatment Algorithm
5.8. Key Industry Events
6. Global Peripheral Arterial Disease Treatment Market Analysis and Forecasts, By Drug Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast By Drug Type, 2020-2035
6.3.1. Antiplatelet Drugs
6.3.2. Cholesterol-Lowering Drugs (Statins)
6.3.3. Anti-hypertensive Drugs
6.3.4. Blood Pressure Medications
6.3.5. Vasodilators
6.3.6. Others
6.4. Market Attractiveness By Drug Type
7. Global Peripheral Arterial Disease Treatment Market Analysis and Forecasts, By Route of Administration
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast By Route of Administration, 2020-2035
7.3.1. Oral
7.3.2. Parenteral
7.4. Market Attractiveness By Route of Administration
8. Global Peripheral Arterial Disease Treatment Market Analysis and Forecasts, By Distribution Channel
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast By Distribution Channel, 2020-2035
8.3.1. Hospital Pharmacies
8.3.2. Retail Pharmacies
8.3.3. Online Pharmacies
8.4. Market Attractiveness By Distribution Channel
9. Global Peripheral Arterial Disease Treatment Market Analysis and Forecasts, By Region
9.1. Key Findings
9.2. Market Value Forecast By Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness By Region
10. North America Peripheral Arterial Disease Treatment Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast By Drug Type, 2020-2035
10.2.1. Antiplatelet Drugs
10.2.2. Cholesterol-Lowering Drugs (Statins)
10.2.3. Anti-hypertensive Drugs
10.2.4. Blood Pressure Medications
10.2.5. Vasodilators
10.2.6. Others
10.3. Market Value Forecast By Route of Administration, 2020-2035
10.3.1. Oral
10.3.2. Parenteral
10.4. Market Value Forecast By Distribution Channel, 2020-2035
10.4.1. Hospital Pharmacies
10.4.2. Retail Pharmacies
10.4.3. Online Pharmacies
10.5. Market Value Forecast By Country, 2020-2035
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Drug Type
10.6.2. By Route of Administration
10.6.3. By Distribution Channel
10.6.4. By Country
11. Europe Peripheral Arterial Disease Treatment Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast By Drug Type, 2020-2035
11.2.1. Antiplatelet Drugs
11.2.2. Cholesterol-Lowering Drugs (Statins)
11.2.3. Anti-hypertensive Drugs
11.2.4. Blood Pressure Medications
11.2.5. Vasodilators
11.2.6. Others
11.3. Market Value Forecast By Route of Administration, 2020-2035
11.3.1. Oral
11.3.2. Parenteral
11.4. Market Value Forecast By Distribution Channel, 2020-2035
11.4.1. Hospital Pharmacies
11.4.2. Retail Pharmacies
11.4.3. Online Pharmacies
11.5. Market Value Forecast By Country/Sub-region, 2020-2035
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Italy
11.5.5. Spain
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Drug Type
11.6.2. By Route of Administration
11.6.3. By Distribution Channel
11.6.4. By Country/Sub-region
12. Asia Pacific Peripheral Arterial Disease Treatment Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast By Drug Type, 2020-2035
12.2.1. Antiplatelet Drugs
12.2.2. Cholesterol-Lowering Drugs (Statins)
12.2.3. Anti-hypertensive Drugs
12.2.4. Blood Pressure Medications
12.2.5. Vasodilators
12.2.6. Others
12.3. Market Value Forecast By Route of Administration, 2020-2035
12.3.1. Oral
12.3.2. Parenteral
12.4. Market Value Forecast By Distribution Channel, 2020-2035
12.4.1. Hospital Pharmacies
12.4.2. Retail Pharmacies
12.4.3. Online Pharmacies
12.5. Market Value Forecast By Country/Sub-region, 2020-2035
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Drug Type
12.6.2. By Route of Administration
12.6.3. By Distribution Channel
12.6.4. By Country/Sub-region
13. Latin America Peripheral Arterial Disease Treatment Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast By Drug Type, 2020-2035
13.2.1. Antiplatelet Drugs
13.2.2. Cholesterol-Lowering Drugs (Statins)
13.2.3. Anti-hypertensive Drugs
13.2.4. Blood Pressure Medications
13.2.5. Vasodilators
13.2.6. Others
13.3. Market Value Forecast By Route of Administration, 2020-2035
13.3.1. Oral
13.3.2. Parenteral
13.4. Market Value Forecast By Distribution Channel, 2020-2035
13.4.1. Hospital Pharmacies
13.4.2. Retail Pharmacies
13.4.3. Online Pharmacies
13.5. Market Value Forecast By Country/Sub-region, 2020-2035
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Drug Type
13.6.2. By Route of Administration
13.6.3. By Distribution Channel
13.6.4. By Country/Sub-region
14. Middle East & Africa Peripheral Arterial Disease Treatment Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast By Drug Type, 2020-2035
14.2.1. Antiplatelet Drugs
14.2.2. Cholesterol-Lowering Drugs (Statins)
14.2.3. Anti-hypertensive Drugs
14.2.4. Blood Pressure Medications
14.2.5. Vasodilators
14.2.6. Others
14.3. Market Value Forecast By Route of Administration, 2020-2035
14.3.1. Oral
14.3.2. Parenteral
14.4. Market Value Forecast By Distribution Channel, 2020-2035
14.4.1. Hospital Pharmacies
14.4.2. Retail Pharmacies
14.4.3. Online Pharmacies
14.5. Market Value Forecast By Country/Sub-region, 2020-2035
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. By Drug Type
14.6.2. By Route of Administration
14.6.3. By Distribution Channel
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player - Competition Matrix (By Tier and Size of companies)
